Q2 Solutions 理解,将有前景的候选药物推向市场需要一个精心规划的策略,该策略包含灵敏、具体且经验证的分析,为开发决策提供信息。因此,我们训练有素的科学家应用前沿技术、自动化平台和最先进的技术,以支持广泛的生物分析服务和 ADME 服务。
Q2 Solutions 全球网络提供从支持药物代谢和药代动力学研究的高通量 ADME 筛选服务和人类清除率预测,到支持临床安全性的药物间相互作用检测和代谢物谱分析的解决方案,以支持药物发现和开发的每个阶段。
我们的生物分析服务包括:
除了以下各节中详述的特定服务外,Q2 Solutions 可以为发现和监管阶段整套内容提供捆绑服务,以便在开发流程的每个步骤做出决策。
There is an increase in the complexity of drug modalities along with the need for more sensitive methods. Immunoassays, while often chosen as the first platform to utilize for assessing...
Translational research programs have been created to provide a better understanding of disease susceptibilities and pathway mechanisms. These programs require integration and analysis of multiple...
Learn more about Merck’s Biospecimen and Biorepository Management System (BBMS) - a transformational informatics project that improves operational visibility, increases efficiency, and maintains...